Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-04 Sale | 2024-03-05 4:24 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 2,447 | $7.77 | $19,013 | 101,479 (Direct) | View |
| 2024-01-29 Sale | 2024-01-30 4:01 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 1,849 | $5 | $9,245 | 103,926 (Direct) | View |
| 2024-01-09 Sale | 2024-01-10 4:30 pm | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 10,874 | $4.37 | $47,519 | 142,361 (Direct) | View |
| 2024-01-09 Sale | 2024-01-10 4:30 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 11,271 | $4.38 | $49,367 | 158,069 (Direct) | View |
| 2024-01-09 Sale | 2024-01-10 4:29 pm | FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO | 14,391 | $4.37 | $62,889 | 371,248 (Direct) | View |
| 2024-01-09 Sale | 2024-01-10 4:29 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 7,028 | $4.37 | $30,712 | 105,775 (Direct) | View |
| 2024-01-02 Sale | 2024-01-03 4:03 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 5,182 | $3.66 | $18,966 | 112,803 (Direct) | View |
| 2023-12-26 Purchase | 2023-12-28 9:30 pm | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 44,630 | $3.72 | $166,024 | 16,491,128 (Indirect) | View |
| 2023-12-18 Sale | 2023-12-19 4:01 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 1,585 | $3.5 | $5,548 | 117,985 (Direct) | View |
| 2023-11-09 Sale | 2023-11-13 4:01 pm | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 24,363 | $2.4 | $58,471 | 153,235 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 4:02 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 4,718 | $2.8 | $13,210 | 119,570 (Direct) | View |
| 2023-08-04 Sale | 2023-08-07 4:01 pm | FATE THERAPEUTICS INC | FATE | Xu Yuan Director | 632 | $3.71 | $2,345 | 9,302 (Direct) | View |
| 2023-07-05 Sale | 2023-07-06 5:19 pm | FATE THERAPEUTICS INC | FATE | Powl Brian T. Chief Commercial Officer | 3,854 | $4.87 | $18,769 | 41,146 (Direct) | View |
| 2023-07-05 Sale | 2023-07-06 5:18 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 5,182 | $4.83 | $25,029 | 124,288 (Direct) | View |
| 2023-06-14 Sale | 2023-06-15 4:05 pm | FATE THERAPEUTICS INC | FATE | Xu Yuan Director | 3,460 | $5.58 | $19,307 | 9,934 (Direct) | View |
| 2023-04-20 Purchase | 2023-04-21 9:55 pm | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 276,639 | $6.1663 | $1,705,829 | 13,135,758 (Indirect) | View |
| 2023-04-18 Sale | 2023-04-19 4:07 pm | FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer | 2,532 | $6.5749 | $16,648 | 140,676 (Direct) | View |
| 2023-04-14 Purchase | 2023-04-17 9:30 pm | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 25,700 | $6 | $154,200 | 33,760,033 (Indirect) | View |
| 2023-04-14 Sale | 2023-04-17 9:30 pm | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 302,339 | $5.84 | $1,765,660 | 33,760,033 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-21 Option Award | 2024-03-25 9:30 pm | 2024-03-21 N/A | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 3,636,364 | $5.499 | 3,893,674 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 425,000 | $0 | 425,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:09 pm | N/A 2034-01-31 | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:09 pm | N/A 2034-01-31 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-12-26 Other | 2023-12-28 9:30 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 1,655,370 | $3.72 | 16,491,128 (Indirect) | View |
| 2023-06-06 Option Award | 2023-06-08 7:22 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |
| 2023-06-06 Option Award | 2023-06-08 7:22 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | Lee Michael Stewart Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:15 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | Xu Yuan Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:13 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | RASTETTER WILLIAM H Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:11 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:10 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | Jooss Karin Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:09 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:08 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | EPSTEIN ROBERT S Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:06 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:05 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-04-14 Other | 2023-04-17 9:30 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 6,592,385 | $5.84 | 33,760,033 (Indirect) | View |
| 2023-04-14 Other | 2023-04-17 9:30 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 91,504 | $29.2 | 33,760,033 (Indirect) | View |
| 2023-04-14 Other | 2023-04-17 9:30 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 109,920 | $5.839 | 33,760,033 (Indirect) | View |
| 2023-04-13 Conversion | 2023-04-17 9:30 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 200,646 | $0 | 33,760,033 (Indirect) | View |
| 2023-02-06 Option Award | 2023-02-07 4:21 pm | N/A 2033-02-05 | FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 4:20 pm | N/A 2033-02-05 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 4:18 pm | N/A 2033-02-05 | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 425,000 | $0 | 425,000 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 4:16 pm | N/A 2033-02-05 | FATE THERAPEUTICS INC | FATE | Powl Brian T. Chief Commercial Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 4:15 pm | N/A 2033-02-05 | FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 4:13 pm | N/A 2033-02-05 | FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2023-01-19 Exercise | 2023-01-20 4:14 pm | N/A 2023-02-06 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 28,461 | $0 | 311,231 (Direct) | View |
| 2023-01-19 Exercise | 2023-01-20 4:14 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 28,461 | $1.37 | 311,231 (Direct) | View |